These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18695790)

  • 1. [Chronic bacterial infection and echocardiographic parameters indicative of pulmonary hypertension in patients with cystic fibrosis].
    Rovedder PM; Ziegler B; Pasin LR; Pinotti AF; Barreto SS; Dalcin Pde T
    J Bras Pneumol; 2008 Jul; 34(7):461-7. PubMed ID: 18695790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa.
    Hendry J; Butler S; Elborn JS; Govan JR; Nelson J; Shale DJ; Webb AK
    J Infect; 2000 Mar; 40(2):164-70. PubMed ID: 10841094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward.
    Döring G; Jansen S; Noll H; Grupp H; Frank F; Botzenhart K; Magdorf K; Wahn U
    Pediatr Pulmonol; 1996 Feb; 21(2):90-100. PubMed ID: 8882212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of pulmonary hypertension evaluated by Doppler echocardiography in a population of adolescent and adult patients with cystic fibrosis.
    Rovedder PM; Ziegler B; Pinotti AF; Menna Barreto SS; Dalcin Pde T
    J Bras Pneumol; 2008 Feb; 34(2):83-90. PubMed ID: 18345451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of mortality in adults with cystic fibrosis.
    Courtney JM; Bradley J; Mccaughan J; O'Connor TM; Shortt C; Bredin CP; Bradbury I; Elborn JS
    Pediatr Pulmonol; 2007 Jun; 42(6):525-32. PubMed ID: 17469153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak.
    Whiteford ML; Wilkinson JD; McColl JH; Conlon FM; Michie JR; Evans TJ; Paton JY
    Thorax; 1995 Nov; 50(11):1194-8. PubMed ID: 8553277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia.
    Jacques I; Derelle J; Weber M; Vidailhet M
    Eur J Pediatr; 1998 May; 157(5):427-31. PubMed ID: 9625343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of pulmonary exacerbations with single and multiple organisms in patients with cystic fibrosis and chronic Burkholderia cepacia infection.
    Mc Manus TE; Moore JE; Crowe M; Dunbar K; Elborn JS
    J Infect; 2003 Jan; 46(1):56-9. PubMed ID: 12504610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension as estimated by Doppler echocardiography in adolescent and adult patients with cystic fibrosis and their relationship with clinical, lung function and sleep findings.
    Ziegler B; Perin C; Casarotto FC; Fagondes SC; Menna-Barreto SS; Dalcin PTR
    Clin Respir J; 2018 Feb; 12(2):754-761. PubMed ID: 27925430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burkholderia cepacia is associated with pulmonary hypertension and increased mortality among cystic fibrosis patients.
    Fauroux B; Hart N; Belfar S; Boulé M; Tillous-Borde I; Bonnet D; Bingen E; Clément A
    J Clin Microbiol; 2004 Dec; 42(12):5537-41. PubMed ID: 15583278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis: inflammatory response to infection with Burkholderia cepacia and Pseudomonas aeruginosa.
    Hendry J; Elborn JS; Nixon L; Shale DJ; Webb AK
    Eur Respir J; 1999 Aug; 14(2):435-8. PubMed ID: 10515426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis.
    Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W
    Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis.
    Blumer JL; Saiman L; Konstan MW; Melnick D
    Chest; 2005 Oct; 128(4):2336-46. PubMed ID: 16236892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary function, serum markers of inflammation, and IgG antibodies to core lipopolysaccharide of Burkholderia cepacia in adults with cystic fibrosis, following colonization with Burkholderia cepacia.
    Hendry J; Nixon L; Dodd M; Elborn JS; Govan J; Shale DJ; Webb AK
    Pediatr Pulmonol; 2000 Jan; 29(1):8-10. PubMed ID: 10613780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome after acquisition of Burkholderia cepacia in patients with cystic fibrosis.
    McCloskey M; McCaughan J; Redmond AO; Elborn JS
    Ir J Med Sci; 2001; 170(1):28-31. PubMed ID: 11440408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
    Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
    J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis.
    Karpati F; Jonasson J
    Mol Cell Probes; 1996 Dec; 10(6):397-403. PubMed ID: 9025076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients.
    Sajjan U; Corey M; Humar A; Tullis E; Cutz E; Ackerley C; Forstner J
    J Med Microbiol; 2001 Jun; 50(6):535-546. PubMed ID: 11393291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Pseudomonas aeruginosa, Burkholderia cepacia complex, and Stenotrophomonas maltophilia in respiratory samples from cystic fibrosis patients using multiplex PCR.
    da Silva Filho LV; Tateno AF; Velloso Lde F; Levi JE; Fernandes S; Bento CN; Rodrigues JC; Ramos SR
    Pediatr Pulmonol; 2004 Jun; 37(6):537-47. PubMed ID: 15114555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppurative mediastinitis secondary to Burkholderia cepacia in a patient with cystic fibrosis.
    George RB; Cartier Y; Casson AG; Hernandez P
    Can Respir J; 2006; 13(4):215-8. PubMed ID: 16779467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.